{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T04:57:54Z","timestamp":1696913874086},"reference-count":22,"publisher":"Akademiai Kiado Zrt.","issue":"3-4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Physiologica Hungarica"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1556\/aphysiol.88.2001.3-4.11","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T13:46:49Z","timestamp":1094046409000},"page":"293-299","source":"Crossref","is-referenced-by-count":4,"title":["Homocysteine and Cystatin C level changes in haemodialysed patients and connection with cerebro- and cardiovascular complications"],"prefix":"10.1556","volume":"88","author":[{"given":"Lajos","family":"L\u0151csey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Szegedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anik\u00f3","family":"D\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"G\u00f6r\u00f6gh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V111134","article-title":"Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study","volume":"11","author":"D. Ducloux","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.V101164","article-title":"Serum Cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine","volume":"10","author":"A. Bostom","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"19","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1681\/ASN.V7112414","article-title":"Homocysteine and folate concentrations in blood from patients treated with haemodialysis","volume":"7","author":"T. Tamura","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1023\/A:1005329427711","article-title":"The role of vitamins in the pathogenesis and treatment of hyperhomocysteinaemia","volume":"20","author":"J. Ubbink","year":"1997","journal-title":"J. Intern. Metab. Dis."},{"key":"21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1365-2362.1997.18807328.x","article-title":"Elevated plasma levels of reduced homocysteine in common variable Immunodeficiency: A marker of enhanced oxidative stress","volume":"27","author":"P. Aukrust","year":"1997","journal-title":"Eur. J. Clin. Invest."},{"key":"6","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/clinchem\/40.10.1921","article-title":"Serum Cystatin C determined by a rapid automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate","volume":"40","author":"A. Khyse","year":"1994","journal-title":"Clin. Chem."},{"key":"3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1681\/ASN.V104891","article-title":"Hyperhomocysteinaemia in chronic renal disease","volume":"10","author":"A. Bostom","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"18","first-page":"77","article-title":"Hyperhomocysteinaemia and end-stage renal disease","volume":"10","author":"A. Gupta","year":"1997","journal-title":"J. Nephrol."},{"key":"4","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","article-title":"Hyperhomocysteinaemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations","volume":"94","author":"K. Robinson","year":"1996","journal-title":"Circulation"},{"key":"7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/08860229809045115","article-title":"Is serum Cystatin C a sensitive marker of glomerular filtration rate (GFR)? A preliminary study on renal transplant patients","volume":"20","author":"M. Plebani","year":"1998","journal-title":"Renal Failure"},{"key":"8","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determination of homocysteinaemia in an elderly population","volume":"270","author":"J. Selhub","year":"1993","journal-title":"JAMA"},{"key":"9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.1997.298","article-title":"Hyperhomocysteinaemia in end-stage disease. Prevalence, etiology and potential relationship to arteriosclerotic outcomes","volume":"52","author":"A. Bostom","year":"1997","journal-title":"Kidney Int."},{"key":"10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/CCLM.1998.032","article-title":"The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma Cystatin","volume":"36","author":"L. Norlund","year":"1998","journal-title":"C. J. Clin. Chem. Lab. Med."},{"key":"14","first-page":"627","article-title":"Homocysteine and heart disease in dialysis patients","volume":"27","author":"A. Rosenthal","year":"1998","journal-title":"Dialysis Transplant."},{"key":"15","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1161\/01.ATV.17.11.2554","article-title":"Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients","volume":"11","author":"A. Bostom","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"16","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/ndt\/12.11.2332","article-title":"Total-, free and protein-bound sulphur amino acids in uraemic patients","volume":"12","author":"M. Suliman","year":"1997","journal-title":"Nephrol. Dial. Transpl."},{"key":"11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.V111149","article-title":"Homocysteine: \u201cexpensive Creatinine\u201d or important, modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients","volume":"11","author":"A. Bostom","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"12","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/01.CIR.99.18.2361","article-title":"Homocysteine and arteriosclerosis: Subclinical and clinical disease associations","volume":"99","author":"A. Bostom","year":"1999","journal-title":"Circulation"},{"key":"13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00043798-199808000-00007","article-title":"Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the Homocysteine hypothesis of vascular disease","volume":"5","author":"R. Clarke","year":"1998","journal-title":"J. Cardiovascular. Risk"},{"key":"17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0021-9150(96)05865-0","article-title":"Hyperhomocysteinaemia, hyperfibrinogenaemia, and lipoprotein excess in maintenance dialysis patients: A matched case-control study","volume":"125","author":"P. Jacques","year":"1996","journal-title":"Atherosclerosis"},{"key":"1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ndt\/15.7.1029","article-title":"Randomised trial of high-flux vs. Low-flux haemodialysis: effects on homocysteine and lipids","volume":"15","author":"A. House","year":"2000","journal-title":"Nephrol. Dial.Transpl."},{"key":"2","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/ndt\/14.12.2810","article-title":"Reversal of hyperhomocysteinaemia in chronic renal failure - is folic acid the answer","volume":"14","author":"Z. Massy","year":"1999","journal-title":"Nephrol. Dial. Transpl."}],"container-title":["Acta Physiologica Hungarica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/aphysiol.88.2001.3-4.11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T08:12:50Z","timestamp":1682755970000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/aphysiol.88.2001.3-4.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":22,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1556\/APhysiol.88.2001.3-4.11"],"URL":"https:\/\/doi.org\/10.1556\/aphysiol.88.2001.3-4.11","relation":{},"ISSN":["0231-424X","1588-2683"],"issn-type":[{"value":"0231-424X","type":"print"},{"value":"1588-2683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}